156 related articles for article (PubMed ID: 31659640)
1. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer.
Baba H; Kanda M; Sawaki K; Umeda S; Miwa T; Shimizu D; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y; Fujii T
Ann Surg Oncol; 2020 Jun; 27(6):2071-2080. PubMed ID: 31659640
[TBL] [Abstract][Full Text] [Related]
2.
Baba H; Kanda M; Sawaki K; Shimizu D; Umeda S; Koike M; Kodera Y; Fujii T
Anticancer Res; 2019 Nov; 39(11):5943-5951. PubMed ID: 31704819
[TBL] [Abstract][Full Text] [Related]
3. Expression of sushi domain containing two reflects the malignant potential of gastric cancer.
Umeda S; Kanda M; Miwa T; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Cancer Med; 2018 Oct; 7(10):5194-5204. PubMed ID: 30259711
[TBL] [Abstract][Full Text] [Related]
4. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
[TBL] [Abstract][Full Text] [Related]
5. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
[TBL] [Abstract][Full Text] [Related]
6. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.
Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y
Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814
[TBL] [Abstract][Full Text] [Related]
7. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.
Miwa T; Kanda M; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
Ann Surg Oncol; 2019 May; 26(5):1535-1543. PubMed ID: 30673899
[TBL] [Abstract][Full Text] [Related]
8. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
[TBL] [Abstract][Full Text] [Related]
9. Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
Miwa T; Kanda M; Shimizu D; Umeda S; Sawaki K; Tanaka H; Tanaka C; Hattori N; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
Br J Cancer; 2021 Apr; 124(8):1449-1460. PubMed ID: 33531692
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
11. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.
Shimizu D; Kanda M; Tanaka H; Kobayashi D; Tanaka C; Hayashi M; Iwata N; Niwa Y; Takami H; Yamada S; Fujii T; Nakayama G; Fujiwara M; Kodera Y
Sci Rep; 2017 Feb; 7():42089. PubMed ID: 28165032
[TBL] [Abstract][Full Text] [Related]
12. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
13. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel hub genes associated with liver metastasis of gastric cancer.
Chang W; Ma L; Lin L; Gu L; Liu X; Cai H; Yu Y; Tan X; Zhai Y; Xu X; Zhang M; Wu L; Zhang H; Hou J; Wang H; Cao G
Int J Cancer; 2009 Dec; 125(12):2844-53. PubMed ID: 19569046
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
Kanda M; Nomoto S; Oya H; Hashimoto R; Takami H; Shimizu D; Sonohara F; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Murotani K; Fujiwara M; Kodera Y
J Exp Clin Cancer Res; 2014 Oct; 33(1):88. PubMed ID: 25330808
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Cytokeratin 20 mRNA Expression in Peripheral Blood and Lymph Nodes Indicates Micrometastasis and Poor Prognosis in Patients With Gastric Carcinoma.
You X; Wang Y; Wu J; Liu Q; Chen D; Tang D; Wang D
Technol Cancer Res Treat; 2019 Jan; 18():1533033819832856. PubMed ID: 30827194
[TBL] [Abstract][Full Text] [Related]
19. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.
Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y
Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594
[TBL] [Abstract][Full Text] [Related]
20. MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer.
Fujiya K; Terashima M; Ohshima K; Aizawa D; Sugino T; Serizawa M; Nakamura K; Nagashima T; Hatakeyama K; Urakami K; Akiyama Y; Tsubosa Y; Kitagawa Y; Yamaguchi K
Gastric Cancer; 2021 Mar; 24(2):341-351. PubMed ID: 32965606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
